BXP: owning the better half of a divided office market

The most consequential thing about BXP's slot at the BofA Securities global real-estate conference is that it is not news at all. Listed companies appear at brokerage shindigs every week, and the announcement tells an investor nothing about the business. But it is a serviceable invitation to consider the company behind it—Boston Properties, the largest publicly traded owner of offices in America—and to ask whether the market has understood what it is really betting on. BXP's conference pitch will be the familiar one: premium buildings, gateway cities, "premier workplaces." The interesting question is whether that positioning is a slogan or a structural edge, and whether the share price has already made the trade.

For most of the past six years, the office market looked like a single, dying asset class. Remote work hollowed out towers, landlords slashed rents, lenders braced for losses, and the national vacancy rate climbed to around 14%. That story was always too blunt. It described the wrong half of the market. The pandemic did not kill offices so much as it split them in two—a bifurcation now plain enough that JLL reports global leasing at post-pandemic highs even as supply shrinks.

BXP sits almost entirely on one side of that divide. Management defines its core urban holdings as the "premier workplaces" of six gateway cities (Boston, New York, Los Angeles, San Francisco, Seattle, Washington), roughly the top 14% of office space and 8% of buildings in those downtown markets. The economics of the two tiers have come apart. Direct vacancy in premier buildings stands near 8%, against 13.5% for the broader market, and prime asking rents carry a premium of more than 60% over non-premier space. Tenants who were culling square footage are instead trading up to the best buildings and signing longer leases, while construction of new towers has all but ceased. In a market scarred by oversupply, the scarcest commodity is a good office, and BXP owns an outsized share of the supply.

The second-quarter numbers, reported in late July, show the strategy converting into operations. Occupancy reached 88.4%, up a full point from the first quarter, with the portfolio 91.3% leased and a 290-basis-point gap of signed deals yet to begin—most before year-end. In the quarter BXP executed 106 leases across 1.8m square feet, about 29% above its decade average for the period, and management raised full-year guidance to $6.99–7.05 in funds from operations per share. The demand is not only cyclical. Boston Dynamics is taking a 320,000-square-foot robotics and artificial-intelligence centre in one redeveloped property; AstraZeneca occupies a 100%-let life-science campus; a new Manhattan tower, 343 Madison Avenue, is already half pre-leased years before its 2029 delivery. Filling the space on hand—management points toward roughly 90% occupancy by year-end, 91% by the end of 2027 and 94–95% by 2028—would translate into meaningful growth in the funds that back BXP's $2.80 annual dividend.

It is tempting to stop there, with a recovering landlord selling at a discount. The trouble is that the accounting flatters the cash. BXP expects cash same-property operating income to stay roughly flat in 2026, because generous free-rent periods delay collection, and it has arranged a $1.2bn construction loan facility for 343 Madison while refinancing a $1bn unsecured bond due this October in a still-elevated rate environment. The recovery is also geographically lopsided: West Los Angeles, parts of Seattle and the financial-and-legal quarters of San Francisco remain sluggish, and the company is still selling assets to trim debt and fund development, taking some dilution in the process. BXP is getting out of its weakest buildings and into its strongest, which is a sound strategy and also an admission that not every tower is coming back.

The share price has noticed the comeback but not indulged it. At just over $64, BXP trades at roughly nine times this year's FFO guidance—cheap against a broad market grown accustomed to thirty- and forty-times earnings, and cheap enough that the ~11% forward FFO yield comfortably covers the dividend. The stock has risen about 39% over three years, a reminder that the "recovery" trade has already been running. What an investor is buying at nine times FFO is not a growth story so much as a bet that the premium segment's occupancy and pricing power carry through to cash: that the 290-basis-point spread of signed-but-uncommenced leases translates into collected rent, that tenants renew at higher spreads rather than retreating, and that the trophy pipeline completes near its projected returns.

Conference appearances will reveal none of this. They are marketing, and BXP's marketing is good—it has to be, because the entire thesis rests on the claim that its buildings belong to a different, tighter market than the office landscape most landlords inhabit. That claim looks increasingly true, and the execution has followed. But the premium is the product of two fragile conditions: that demand for premier space keeps outpacing the rest, and that BXP's own tenants actually pay up when free-rent periods expire. Investors should treat the current price as the market's roughly correct guess that office has two fates, not one—and in the two-tier market, owning the better half is not the same as owning the future.